|
Name |
Phomopsterone A
|
| Molecular Formula | C29H42O6 | |
| IUPAC Name* |
methyl (1R,2R,5R,6R,9R,11R,12R,13S)-12-hydroxy-1,5-dimethyl-6-[(1S)-1-[(2S,3S)-3-[(2R)-3-methylbutan-2-yl]oxiran-2-yl]ethyl]-14-oxo-10-oxapentacyclo[11.3.1.02,11.05,9.09,11]heptadec-15-ene-16-carboxylate
|
|
| SMILES |
C[C@@H]([C@H]1CC[C@@]23[C@@]1(CC[C@H]4[C@@]2(O3)[C@@H]([C@@H]5C[C@]4(C(=CC5=O)C(=O)OC)C)O)C)[C@H]6[C@@H](O6)[C@H](C)C(C)C
|
|
| InChI |
InChI=1S/C29H42O6/c1-14(2)15(3)22-23(34-22)16(4)18-8-11-28-27(18,6)10-9-21-26(5)13-17(24(31)29(21,28)35-28)20(30)12-19(26)25(32)33-7/h12,14-18,21-24,31H,8-11,13H2,1-7H3/t15-,16+,17-,18-,21-,22+,23+,24-,26+,27-,28-,29-/m1/s1
|
|
| InChIKey |
GQGRHHQOPCZNAP-QMOBPBEPSA-N
|
|
| Synonyms |
Phomopsterone A
|
|
| CAS | NA | |
| PubChem CID | 139049579 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 486.6 | ALogp: | 4.2 |
| HBD: | 1 | HBA: | 6 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 88.7 | Aromatic Rings: | 6 |
| Heavy Atoms: | 35 | QED Weighted: | 0.448 |
| Caco-2 Permeability: | -5.141 | MDCK Permeability: | 0.00005560 |
| Pgp-inhibitor: | 0.588 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.018 |
| 30% Bioavailability (F30%): | 0.766 |
| Blood-Brain-Barrier Penetration (BBB): | 0.516 | Plasma Protein Binding (PPB): | 83.78% |
| Volume Distribution (VD): | 1.148 | Fu: | 6.01% |
| CYP1A2-inhibitor: | 0.019 | CYP1A2-substrate: | 0.98 |
| CYP2C19-inhibitor: | 0.137 | CYP2C19-substrate: | 0.946 |
| CYP2C9-inhibitor: | 0.176 | CYP2C9-substrate: | 0.009 |
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.14 |
| CYP3A4-inhibitor: | 0.83 | CYP3A4-substrate: | 0.918 |
| Clearance (CL): | 11.808 | Half-life (T1/2): | 0.532 |
| hERG Blockers: | 0.078 | Human Hepatotoxicity (H-HT): | 0.263 |
| Drug-inuced Liver Injury (DILI): | 0.675 | AMES Toxicity: | 0.014 |
| Rat Oral Acute Toxicity: | 0.777 | Maximum Recommended Daily Dose: | 0.029 |
| Skin Sensitization: | 0.072 | Carcinogencity: | 0.226 |
| Eye Corrosion: | 0.068 | Eye Irritation: | 0.031 |
| Respiratory Toxicity: | 0.979 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004615 | ![]() |
0.385 | D06AEO | ![]() |
0.287 | ||
| ENC004858 | ![]() |
0.336 | D0Y2YP | ![]() |
0.279 | ||
| ENC006032 | ![]() |
0.333 | D04SFH | ![]() |
0.273 | ||
| ENC003940 | ![]() |
0.331 | D0I2SD | ![]() |
0.273 | ||
| ENC005013 | ![]() |
0.321 | D0Q4SD | ![]() |
0.270 | ||
| ENC005015 | ![]() |
0.321 | D04GJN | ![]() |
0.264 | ||
| ENC004740 | ![]() |
0.321 | D0Y7LD | ![]() |
0.262 | ||
| ENC001640 | ![]() |
0.321 | D06IIB | ![]() |
0.261 | ||
| ENC005779 | ![]() |
0.321 | D0K7HU | ![]() |
0.259 | ||
| ENC002480 | ![]() |
0.316 | D0KR5B | ![]() |
0.258 | ||